litlas
Log inCreate account

Ivan M. Robbins

Active 1998–2025

56
Papers
18,699
Citations
52
h-index
54
i10-index

Citations

Citations per year for Ivan M. Robbins1960: 4 citations1985: 1 citations1997: 1 citations1999: 11 citations2000: 15 citations2001: 12 citations2002: 47 citations2003: 69 citations2004: 97 citations2005: 101 citations2006: 120 citations2007: 89 citations2008: 131 citations2009: 160 citations2010: 181 citations2011: 191 citations2012: 209 citations2013: 249 citations2014: 175 citations2015: 158 citations2016: 170 citations2017: 111 citations2018: 134 citations2019: 335 citations2020: 383 citations2021: 253 citations2022: 253 citations2023: 134 citations2024: 238 citations2025: 71 citations2026: 5 citations1961–1984: no citations, so these years are not shown1986–1996: no citations, so these years are not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,432 citing papers, 28.4% of this breakdownUnited Kingdom: 435 citing papers, 8.6% of this breakdownFrance: 385 citing papers, 7.7% of this breakdownGermany: 377 citing papers, 7.5% of this breakdownCanada: 242 citing papers, 4.8% of this breakdownItaly: 240 citing papers, 4.8% of this breakdownChina: 223 citing papers, 4.4% of this breakdownNetherlands: 183 citing papers, 3.6% of this breakdownSwitzerland: 135 citing papers, 2.7% of this breakdownJapan: 135 citing papers, 2.7% of this breakdownBelgium: 133 citing papers, 2.6% of this breakdownAustria: 132 citing papers, 2.6% of this breakdown
0%28.4%Other 19.6%

Institutions

Fields

  • Medicine91.8%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Neuroscience1.5%
  • Immunology and Microbiology0.7%
  • Environmental Science0.2%
  • Computer Science0.2%
  • Other0.8%

Topics

  • Pulmonary Hypertension Research and Treatments25.5%
  • Cardiovascular Function and Risk Factors4.7%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis4.2%
  • Cardiovascular Issues in Pregnancy3.5%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.1%
  • Heart Failure Treatment and Management3%
  • Other56%

Coauthors

All papers

Open in search
  1. Updated Clinical Classification of Pulmonary Hypertension

    Authors: Gérald Simonneau, Michael Α. Gatzoulis, Ian Adatia, David S. Celermajer, Chris Denton, Hossein Ardeschir Ghofrani, Miguel Ángel Gómez Sánchez, Raman Kumar, Michael J. Landzberg, Roberto F. Machado, Horst Olschewski, Ivan M. Robbins, Rogiero Souza - Journal of the American College of Cardiology 2013 cited by 4,193

  2. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

    Authors: Christopher J. Rhodes, Ken Batai, Marta Bleda, Matthias Haimel, Laura Southgate, Marine Germain, Michael W. Pauciulo, Charaka Hadinnapola, Jurjan Aman, Barbara Girerd, Amit Arora, Jo Knight, Ken B. Hanscombe, Jason H. Karnes, Marika Kaakinen, Henning Gall, Anna Ulrich, Lars Harbaum, Inês Cebola, Jorge Ferrer, Katie A. Lutz, Emilia M. Swietlik, Ferhaan Ahmad, Philippe Amouyel, Stephen L. Archer, Rahul Argula, Eric D. Austin, David B. Badesch, Sahil Bakshi, Christopher F. Barnett, Raymond L. Benza, Nitin Bhatt, Harm Jan Bogaard, Charles D. Burger, Murali M. Chakinala, Colin Church, Gerry Coghlan, Robin Condliffe, Paul A. Corris, Cesare Danesino, Stéphanie Debette, C. Gregory Elliott, Jean Elwing, Mélanie Eyries, Terry Fortin, André Franke, Robert P. Frantz, Adaani Frost, Joe G. N. Garcia, Stefano Ghio, Hossein-Ardeschir Ghofrani, J. Simon R. Gibbs, John B. Harley, Hua He, Nicholas S. Hill, Russel Hirsch, Arjan C. Houweling, Luke Howard, D. Dunbar Ivy, David G. Kiely, James R. Klinger, Gábor Kovács, Tim Lahm, Matthias Laudes, Rajiv D. Machado, Robert V. MacKenzie Ross, Keith Marsolo, Lisa J. Martin, Shahin Moledina, David Montani, Steven D. Nathan, Michael Newnham, Andrea Olschewski, Horst Olschewski, Ronald J. Oudiz, Willem H. Ouwehand, Andrew J. Peacock, Joanna Pepke‐Żaba, Zia Ur Rehman, Ivan M. Robbins, Dan M. Roden, Erika B. Rosenzweig, Ghulam Saydain, Laura Scelsi, Robert Schilz, Werner Seeger, Christian M. Shaffer, Robert W. Simms, Marc A. Simon, Olivier Sitbon, Jay Suntharalingam, Haiyang Tang, Alexander Tchourbanov, Thenappan Thenappan, Fernando Torres, Mark Toshner, Carmen Treacy, Anton Vonk Noordegraaf, Quinten Waisfisz, Anna K. Walsworth and 18 more - The Lancet Respiratory Medicine 2018 cited by 213

  3. Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension

    Authors: Vallerie V. McLaughlin, Raymond L. Benza, Lewis J. Rubin, Richard N. Channick, Robert Voswinckel, Victor F. Tapson, Ivan M. Robbins, Horst Olschewski, Melvyn Rubenfire, Werner Seeger - Journal of the American College of Cardiology 2010 cited by 551

  4. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension

    Authors: Anna R. Hemnes, Anandharajan Rathinasabapathy, Eric A. Austin, Evan L. Brittain, Erica J. Carrier, Xinping Chen, Joshua P. Fessel, Candice D. Fike, Peter P. Fong, Niki Fortune, Robert E. Gerszten, Jennifer Johnson, Mark R. Kaplowitz, John H. Newman, Robert N. Piana, Meredith E. Pugh, Todd W. Rice, Ivan M. Robbins, Lisa Wheeler, Chang Yu, James E. Loyd, James West - European Respiratory Journal 2018 cited by 227

  5. Human PAH is characterized by a pattern of lipid-related insulin resistance

    Authors: Anna R. Hemnes, James M. Luther, Christopher J. Rhodes, Jason P. Burgess, James Carlson, Run Fan, Joshua P. Fessel, Niki Fortune, Robert E. Gerszten, Stephen Halliday, Rezzan Hekmat, Luke Howard, John H. Newman, Kevin D. Niswender, Meredith E. Pugh, Ivan M. Robbins, Quanhu Sheng, Cyndya A. Shibao, Yu Shyr, Susan Sumner, Megha Talati, John Wharton, Martin R. Wilkins, Fei Ye, Chang Yu, James West, Evan L. Brittain - JCI Insight 2019 cited by 114

  6. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

    Authors: Richard N. Channick, G Simonneau, Olivier Sitbon, Ivan M. Robbins, Adaani Frost, Victor F. Tapson, David B. Badesch, Sébastiên Roux, Maurizio Rainisio, Frédéric Bodin, Lewis J. Rubin - The Lancet 2001 cited by 1,524

  7. Longitudinal Analysis Casts Doubt on the Presence of Genetic Anticipation in Heritable Pulmonary Arterial Hypertension

    Authors: Emma K. Larkin, John H. Newman, Eric D. Austin, Anna R. Hemnes, Lisa Wheeler, Ivan M. Robbins, James West, John A. Phillips, Rizwan Hamid, James E. Loyd - American Journal of Respiratory and Critical Care Medicine 2012 cited by 216

  8. Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry

    Authors: Kim M. Kerr, C. Gregory Elliott, Kelly Chin, Raymond L. Benza, Richard N. Channick, R. Duane Davis, Feng He, Andrea Z. LaCroix, Michael M. Madani, Vallerie V. McLaughlin, Myung Park, Ivan M. Robbins, Victor F. Tapson, Jeffrey R. Terry, Victor Test, Sonia Jain, William R. Auger - CHEST Journal 2021 cited by 73

  9. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

    Authors: Na Zhu, Emilia M. Swietlik, Carrie L. Welch, Michael W. Pauciulo, Jacob Hagen, Xueya Zhou, Yicheng Guo, Johannes Karten, Divya Pandya, Tobias Tilly, Katie A. Lutz, Jennifer M. Martin, Carmen M. Treacy, Erika B. Rosenzweig, Usha Krishnan, Anna W. Coleman, Claudia Gonzaga‐Jauregui, Allan Lawrie, Richard C. Trembath, Martin R. Wilkins, Russel Hirsch, R.J. White, Marc A. Simon, David B. Badesch, Erika B. Rosenzweig, Charles D. Burger, Murali M. Chakinala, Thenappan Thenappan, Greg Elliott, Robert W. Simms, Harrison W. Farber, Robert P. Frantz, Jean Elwing, Nicholas S. Hill, D. Dunbar Ivy, James Klinger, Steven D. Nathan, Ronald J. Oudiz, Ivan M. Robbins, Robert Schilz, Terry Fortin, Jeffrey Wilt, Delphine Yung, Eric D. Austin, Ferhaan Ahmad, Nitin Bhatt, Tim Lahm, Adaani Frost, Zeenat Safdar, Zia Ur Rehman, Robert Walter, Fernando Torres, Sahil Bakshi, Stephen L. Archer, Rahul Argula, Christopher F. Barnett, Raymond L. Benza, Ankit A. Desai, Veeranna Maddipati, Harm Jan Bogaard, Colin Church, Gerry Coghlin, Robin Condliffe, Mélanie Eyries, Henning Gall, Stefano Ghio, Barbara Girerd, Simon Holden, Luke Howard, Marc Humbert, David G. Kiely, Gábor Kovács, Jim Lordan, Rajiv D. Machado, Robert V. MacKenzie Ross, Colm McCabe, Jennifer M. Martin, Shahin Moledina, David Montani, Horst Olschewski, Christopher J. Penkett, Joanna Pepke‐Żaba, Laura Price, Christopher J. Rhodes, Werner Seeger, Florent Soubrier, Laura Southgate, Jay Suntharalingam, Andrew J. Swift, Mark Toshner, Carmen Treacy, Anton Vonk Noordegraaf, John Wharton, Jim M. Wild, Stephen J. Wort, National Cohort Study of Idiopathic and Heritable PAH, Harm Jan Bogaard, Colin Church, Gerry Coghlin, Robin Condliffe and 37 more - Genome Medicine 2021 cited by 85

  10. Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

    Authors: David B. Badesch, Victor F. Tapson, Michael D. McGoon, Bruce H. Brundage, Lewis J. Rubin, Fredrick M. Wigley, Stuart Rich, Robyn J. Barst, Pamela S. Barrett, Kenneth M. Kral, Maria M. Jöbsis, James E. Loyd, Srinivas Murali, Adaani Frost, Reda E. Girgis, Robert C. Bourge, David Ralph, C. Gregory Elliott, Nicholas S. Hill, David Langleben, Robert Schilz, Vallerie V. McLaughlin, Ivan M. Robbins, Bertron Μ. Groves, Shelley Shapiro, Thomas A. Medsger, Seán Gaine, Evelyn M. Horn, James C. Decker, Katharine Knobil - Annals of Internal Medicine 2000 cited by 1,075

  11. Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension

    Authors: Evan L. Brittain, Kevin D. Niswender, Vineet Agrawal, Xinping Chen, Run Fan, Meredith E. Pugh, Todd W. Rice, Ivan M. Robbins, Haocan Song, Christopher Thompson, Fei Ye, Chang Yu, He Zhu, James West, John H. Newman, Anna R. Hemnes - Journal of the American Heart Association 2020 cited by 81

  12. Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT

    Authors: Marc de Perrot, Deepa Gopalan, David P. Jenkins, Iréne Lang, Élie Fadel, Marion Delcroix, Raymond L. Benza, Gustavo A. Heresi, Manreet Kanwar, John Granton, Micheal McInnis, Frederikus A. Klok, Kim M. Kerr, Joanna Pepke‐Żaba, Mark Toshner, Anastasia Bykova, Andrea Maria D’Armini, Ivan M. Robbins, Michael M. Madani, David C. McGiffin, Christoph B. Wiedenroth, Sebastian Mafeld, Isabelle Opitz, Olaf Mercier, Patricia A. Uber, Robert P. Frantz, William R. Auger - The Journal of Heart and Lung Transplantation 2021 cited by 75

  13. Serum Endostatin Is a Genetically Determined Predictor of Survival in Pulmonary Arterial Hypertension

    Authors: Rachel L. Damico, Todd M. Kolb, Lidenys Valera, Lan Wang, Traci Housten, Ryan J. Tedford, David A. Kass, Nicholas Rafaels, Li Gao, Kathleen C. Barnes, Raymond L. Benza, James Rand, Rizwan Hamid, James E. Loyd, Ivan M. Robbins, Anna R. Hemnes, Wendy K. Chung, Eric D. Austin, Michael Drummond, Stephen C. Mathai, Paul M. Hassoun - American Journal of Respiratory and Critical Care Medicine 2014 cited by 107

  14. Relative Change in Donor-Derived Cell-free DNA is Superior to Absolute Values for Diagnosis of Acute Lung Allograft Dysfunction

    Authors: Anil J. Trindade, Kaitlyn C. Chapin, Jennifer N. Gray, Y. Furuya, Amy Mullican, Haley Hoy, Caitlin T. Demarest, Ivan M. Robbins, Matthew Bacchetta, D Erasmus, Ciara M. Shaver - Transplantation Direct 2023 cited by 18

  15. Pathologic assessment of vasculopathies in pulmonary hypertension

    Authors: Giuseppe G. Pietra, Frédérique Capron, Susan Stewart, Ornella Leone, Marc Humbert, Ivan M. Robbins, Lynne Reid, Rubin M. Tuder - Journal of the American College of Cardiology 2004 cited by 713

  16. Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension

    Authors: Tufik R. Assad, Bradley A. Maron, Ivan M. Robbins, Meng Xu, Shi Huang, Frank E. Harrell, Eric Farber‐Eger, Quinn S. Wells, Gaurav Choudhary, Anna R. Hemnes, Evan L. Brittain - JAMA Cardiology 2017 cited by 164

  17. T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension

    Authors: Eric D. Austin, Michael T. Rock, Claudio A. Mosse, Cindy L. Vnencak‐Jones, Sandra Yoder, Ivan M. Robbins, James E. Loyd, Barbara Meyrick - Respiratory Medicine 2009 cited by 98

  18. United States Pulmonary Hypertension Scientific Registry

    Authors: Jessica B. Badlam, David B. Badesch, Eric D. Austin, Raymond L. Benza, Wendy K. Chung, Harrison W. Farber, Kathy Feldkircher, Adaani Frost, Abby Poms, Katie A. Lutz, Michael W. Pauciulo, Chang Yu, William C. Nichols, C. Gregory Elliott, Robert W. Simms, Terry Fortin, Zeenat Safdar, Charles D. Burger, Robert P. Frantz, Nicholas S. Hill, Sophia Airhart, Jean Elwing, Marc A. Simon, R.J. White, Ivan M. Robbins, Murali M. Chakinala - CHEST Journal 2020 cited by 64

  19. Updated Clinical Classification of Pulmonary Hypertension

    Authors: Gérald Simonneau, Ivan M. Robbins, Maurice Beghetti, Richard N. Channick, Marion Delcroix, Christopher P. Denton, C. Gregory Elliott, Seán Gaine, Mark T. Gladwin, Zhi‐Cheng Jing, Michael J. Krowka, David Langleben, Norifumi Nakanishi, Rogério Souza - Journal of the American College of Cardiology 2009 cited by 2,071

  20. EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis

    Authors: D. Hunter Best, Kelli Sumner, Eric D. Austin, Wendy K. Chung, Lynette Brown, Alain Borczuk, Erika B. Rosenzweig, Pınar Bayrak‐Toydemir, Rong Mao, Barbara C. Cahill, Henry D. Tazelaar, Kevin O. Leslie, Anna R. Hemnes, Ivan M. Robbins, C. Gregory Elliott - CHEST Journal 2013 cited by 216

  21. The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: Demonstration of a ceiling effect

    Authors: Adaani Frost, David Langleben, Ronald J. Oudiz, Nicholas S. Hill, Evelyn M. Horn, Vallerie V. McLaughlin, Ivan M. Robbins, Shelley Shapiro, Victor F. Tapson, Dianne Zwicke, Teresa DeMarco, Robert Schilz, Melvyn Rubenfire, Robyn J. Barst - Vascular Pharmacology 2005 cited by 188

  22. Sitaxsentan Therapy for Pulmonary Arterial Hypertension

    Authors: Robyn J. Barst, David Langleben, Adaani Frost, Evelyn M. Horn, Ronald J. Oudiz, Shelley Shapiro, Vallerie V. McLaughlin, Nicholas S. Hill, Victor F. Tapson, Ivan M. Robbins, Diane Zwicke, Benjamin Duncan, Richard A. F. Dixon, Lyn R. Frumkin - American Journal of Respiratory and Critical Care Medicine 2003 cited by 707

  23. Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension

    Authors: Marius M. Hoeper, Joan Albert Barberà, Richard N. Channick, Paul M. Hassoun, Iréne Lang, Alessandra Manes, Fernando J. Martínez, Robert Naeije, Horst Olschewski, Joanna Pepke‐Żaba, Margaret M. Redfield, Ivan M. Robbins, Rogério Souza, Adam Torbicki, Michael D. McGoon - Journal of the American College of Cardiology 2009 cited by 396

  24. High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension

    Authors: Ivan M. Robbins, Anna R. Hemnes, Meredith E. Pugh, Evan L. Brittain, David Zhao, Robert N. Piana, Pete Fong, John H. Newman - Circulation Heart Failure 2013 cited by 177